Filed: 2/17/2026ACC: 0001636587-26-000005
📋 What this filing means
ACORN CAPITAL ADVISORS, LLC filed this quarterly 13F‑HR report disclosing 21 equity positions with a total reported market value of $295.13M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
21
Positions
$295.13M
Total AUM (reported)
33.45M
Total Shares
Allocation by class
COM$259.91M88.1%
COM NEW$12.87M4.4%
COM STK$9.34M3.2%
CLASS A COM$8.24M2.8%
COMMON STOCK$4.77M1.6%
Portfolio Concentration
Top 3$151.45M51.3%
4–10$110.40M37.4%
11–25$33.29M11.3%
Top 3 weight
51.3%
Top 10 weight
88.7%
Voting Authority Distribution
Total shares with voting rights: 33.45M
Sole
Full voting authority
33.45M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole21
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings21
Rows:
TERNS PHARMACEUTICALS INC
SOLEShares1.75M
TypeSH
Market value$70.55M
23.90%
Sole
1.75M
Shared
0.00
None
0.00
CG ONCOLOGY INC
SOLEShares1.13M
TypeSH
Market value$46.98M
15.92%
Sole
1.13M
Shared
0.00
None
0.00
UROGEN PHARMA LTD
SOLEShares1.45M
TypeSH
Market value$33.92M
11.49%
Sole
1.45M
Shared
0.00
None
0.00
TREVI THERAPEUTICS INC
SOLEShares2.14M
TypeSH
Market value$26.85M
9.10%
Sole
2.14M
Shared
0.00
None
0.00
PUMA BIOTECHNOLOGY INC
SOLEShares4.13M
TypeSH
Market value$24.58M
8.33%
Sole
4.13M
Shared
0.00
None
0.00
CANDEL THERAPEUTICS INC
SOLEShares2.58M
TypeSH
Market value$14.58M
4.94%
Sole
2.58M
Shared
0.00
None
0.00
CYBIN INC
SOLEShares1.57M
TypeSH
Market value$12.87M
4.36%
Sole
1.57M
Shared
0.00
None
0.00
VERASTEM INC
SOLEShares1.47M
TypeSH
Market value$11.34M
3.84%
Sole
1.47M
Shared
0.00
None
0.00
BICARA THERAPEUTICS
SOLEShares643.38K
TypeSH
Market value$10.83M
3.67%
Sole
643.38K
Shared
0.00
None
0.00
PROTARA THERAPEUTICS INC
SOLEShares1.75M
TypeSH
Market value$9.34M
3.16%
Sole
1.75M
Shared
0.00
None
0.00
ONKURE THERAPEUTICS INC
SOLEShares2.84M
TypeSH
Market value$8.24M
2.79%
Sole
2.84M
Shared
0.00
None
0.00
CARDIF ONCOLOGY INC
SOLEShares1.96M
TypeSH
Market value$5.51M
1.87%
Sole
1.96M
Shared
0.00
None
0.00
ATHIRA PHARMA INC.
SOLEShares501.74K
TypeSH
Market value$3.80M
1.29%
Sole
501.74K
Shared
0.00
None
0.00
JASPER THERAPEUTICS
SOLEShares1.79M
TypeSH
Market value$3.27M
1.11%
Sole
1.79M
Shared
0.00
None
0.00
AURA BIOSCIENCES INC
SOLEShares595.74K
TypeSH
Market value$3.25M
1.10%
Sole
595.74K
Shared
0.00
None
0.00
WHITEHAWK THERAPEUTICS INC
SOLEShares1.14M
TypeSH
Market value$2.76M
0.93%
Sole
1.14M
Shared
0.00
None
0.00
BIOATLA INC
SOLEShares4.84M
TypeSH
Market value$2.76M
0.93%
Sole
4.84M
Shared
0.00
None
0.00
Q32 BIO INC.
SOLEShares493.43K
TypeSH
Market value$1.64M
0.56%
Sole
493.43K
Shared
0.00
None
0.00
X4 PHARMACEUTICALS INC
SOLEShares273.35K
TypeSH
Market value$1.09M
0.37%
Sole
273.35K
Shared
0.00
None
0.00
ACRIVON THERAPEUTICS INC
SOLEShares405.24K
TypeSH
Market value$976.6K
0.33%
Sole
405.24K
Shared
0.00
None
0.00
VYNE THERAPEUTICS INC
SOLEShares1.43K
TypeSH
Market value$827.00
<0.01%
Sole
1.43K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
TERNS PHARMACEUTICALS INCSOLE | COM | 1.75M | SH | $70.55M 23.90% | 1.75M | 0.00 | 0.00 |
CG ONCOLOGY INCSOLE | COM | 1.13M | SH | $46.98M 15.92% | 1.13M | 0.00 | 0.00 |
UROGEN PHARMA LTDSOLE | COM | 1.45M | SH | $33.92M 11.49% | 1.45M | 0.00 | 0.00 |
TREVI THERAPEUTICS INCSOLE | COM | 2.14M | SH | $26.85M 9.10% | 2.14M | 0.00 | 0.00 |
PUMA BIOTECHNOLOGY INCSOLE | COM | 4.13M | SH | $24.58M 8.33% | 4.13M | 0.00 | 0.00 |
CANDEL THERAPEUTICS INCSOLE | COM | 2.58M | SH | $14.58M 4.94% | 2.58M | 0.00 | 0.00 |
CYBIN INCSOLE | COM NEW | 1.57M | SH | $12.87M 4.36% | 1.57M | 0.00 | 0.00 |
VERASTEM INCSOLE | COM | 1.47M | SH | $11.34M 3.84% | 1.47M | 0.00 | 0.00 |
BICARA THERAPEUTICSSOLE | COM | 643.38K | SH | $10.83M 3.67% | 643.38K | 0.00 | 0.00 |
PROTARA THERAPEUTICS INCSOLE | COM STK | 1.75M | SH | $9.34M 3.16% | 1.75M | 0.00 | 0.00 |
ONKURE THERAPEUTICS INCSOLE | CLASS A COM | 2.84M | SH | $8.24M 2.79% | 2.84M | 0.00 | 0.00 |
CARDIF ONCOLOGY INCSOLE | COM | 1.96M | SH | $5.51M 1.87% | 1.96M | 0.00 | 0.00 |
ATHIRA PHARMA INC.SOLE | COMMON STOCK | 501.74K | SH | $3.80M 1.29% | 501.74K | 0.00 | 0.00 |
JASPER THERAPEUTICSSOLE | COM | 1.79M | SH | $3.27M 1.11% | 1.79M | 0.00 | 0.00 |
AURA BIOSCIENCES INCSOLE | COM | 595.74K | SH | $3.25M 1.10% | 595.74K | 0.00 | 0.00 |
WHITEHAWK THERAPEUTICS INCSOLE | COM | 1.14M | SH | $2.76M 0.93% | 1.14M | 0.00 | 0.00 |
BIOATLA INCSOLE | COM | 4.84M | SH | $2.76M 0.93% | 4.84M | 0.00 | 0.00 |
Q32 BIO INC.SOLE | COM | 493.43K | SH | $1.64M 0.56% | 493.43K | 0.00 | 0.00 |
X4 PHARMACEUTICALS INCSOLE | COM | 273.35K | SH | $1.09M 0.37% | 273.35K | 0.00 | 0.00 |
ACRIVON THERAPEUTICS INCSOLE | COMMON STOCK | 405.24K | SH | $976.6K 0.33% | 405.24K | 0.00 | 0.00 |
VYNE THERAPEUTICS INCSOLE | COM | 1.43K | SH | $827.00 <0.01% | 1.43K | 0.00 | 0.00 |